Anglo-Swedish drugs giant AstraZeneca has tapped the bond market with an issue of notes in two tranches.
The group has successfully issued $1bn of 7-year fixed rate notes with a coupon of 1.95% and $1bn of 30-year fixed rate notes with a coupon of 4%.
The proceeds of the issue will be used for debt refinancing and general corporate purposes.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
JH
-
Cash in on the growth prospects of Europe's companiesOpinion Marcel Stötzel, co-portfolio manager of the Fidelity European Trust, selects three stocks
-
Is the AI boom another dotcom bubble?25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
